Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor Meeting Abstract


Authors: Scher, H. I.; Fizazi, K.; Saad, F.; Chi, K. N.; Taplin, M. E.; Sternberg, C. N.; Armstrong, A. J.; Hirmand, M.; Forer, D.; De Bono, J. S.
Abstract Title: Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor
Meeting Title: 2013 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 6 Suppl.
Meeting Dates: 2013 Feb 14-16
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-02-20
Language: English
ACCESSION: WOS:000333679600010
DOI: 10.1200/jco.2013.31.6_suppl.6
PROVIDER: wos
Notes: Meeting Abstract: 6 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard Scher
    1130 Scher